• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number PXC121000
Device Problems Premature Activation (1484); Material Separation (1562); Malposition of Device (2616)
Patient Problem Occlusion (1984)
Event Date 11/30/2015
Event Type  Injury  
Manufacturer Narrative
Concomitant products: patient medications: albuterol, prevecal, singulair, clonamax, hydrocodine, nitro-time, methimazole, procardin.The review of the manufacturing paperwork verified that the lot(s) met all pre-release specifications.(b)(4).
 
Event Description
On (b)(6) 2015, the patient was treated for an abdominal aortic aneurysm.It was reported that during the procedure a pxc121000 came apart at the trailing olive, which caused the graft and the leading olive to separate and the device to deploy prematurely in a location other than intended.It was reported the patient had very small vessels, and the physician had previously dilated the access vessels by implanting gore viabahn endoprosthesis.A 12fr sheath was used but could not be pushed to the intended location.It was reported the physician could not get device into the gate of the gore excluder aaa endoprosthesis so the pxc121000 was pulled back and that is when the device leading olive separated and the device deployed in an unintended location at the bifurcation covering the hypogastric artery.The physician snared the leading olive and catheter, he then bridged another endoprosthesis from the bifurcation to the gore excluder aaa endoprosthesis.The physician is choosing to wait and see how the patient tolerates the covered hypo gastric artery.The physician has requested a response from gore.The device catheter will be returned to gore for evaluation.
 
Manufacturer Narrative
According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), iliac artery treatment diameter range of 8 ¿ 18.5 mm and iliac distal vessel seal zone length of at least 10 mm.Additionally the ifu states; do not rotate the contralateral leg delivery catheter during delivery, positioning or deployment.Catheter breakage or premature deployment may occur.Do not advance the device outside of the sheath.The sheath will protect the device from catheter breakage or premature deployment while tracking it into position.Do not continue advancing any portion of the delivery system if resistance is felt during advancement of the guidewire, sheath, or catheter.Stop and assess the cause of resistance.Vessel or catheter damage may occur.Do not attempt to withdraw any un-deployed endoprosthesis through the introducer sheath.The sheath and catheter must be removed together.
 
Manufacturer Narrative
Added engineering evaluation results: as part of the investigation of this event, an engineering evaluation has been completed.The pxc12100 was returned to gore for evaluation, the evaluation revealed the following: the leading end of the catheter had separated from the catheter body at the trailing olive.The guidewire lumen had fractured at the trailing olive bond on the catheter.There was a twist in the guidewire lumen which is indicative of the device being rotated.The root cause for the broken leading end of the catheter could not be determined with the currently available information, however, used outside the gore® excluder® aaa endoprosthesis instructions for use (ifu) likely contributed to the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL SUNNYVALE B/P
1327 orleans drive
sunnyvale CA 94089
Manufacturer Contact
natalie putnam
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key5323028
MDR Text Key34968524
Report Number2953161-2015-00153
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 01/20/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2018
Device Catalogue NumberPXC121000
Device Lot Number14131687
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/08/2015
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/23/2015
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received01/04/2016
01/26/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/13/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age79 YR
Patient Weight41
-
-